LPLuc. A. Pierard

Luc. A. Pierard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luc. A. Pierard has a total of 118 co-authors. Here are the top co-authors by number of shared publications:

  • Patrizio Lancellotti

    GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège Hospital , Liège

    22 shared publications
  • Patrizio Lancellotti

    Department of Cardiovascular Science, Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA) Cardiovascular Science, Heart Valve Clinic, Imaging Cardiology, University of Liège Hospital, Belgium (P.L.).

    11 shared publications
  • Raluca Dulgheru

    Service de Cardiologie, CHU Sart Tilman, Domaine Universitaire du Sart Tilman B35, 4000, Liege, Belgium

    9 shared publications
  • Julien Magne

    Limoges University Hospital Center, Cardiology Department, Dupuytren Hospital, Limoges, France; National Institute for Health and Medical Research (INSERM) 1094, Faculty of Medicine of Limoges, Limoges, France

    7 shared publications
  • Julien Magne

    CHU Limoges, Limoges, France

    7 shared publications
  • Bernard Iung

    Hôpital Bichat, Paris, France

    4 shared publications

Latest Publications

  • Exercise Echocardiography

    by Luc A. Piérard, Eugenio Picano


  • Primary mitral regurgitation and risk models for predicting outcome: time to move to artificial intelligence?

    by Luc Pierard, Bernard Cosyns

    This editorial refers to ‘Data-driven mortality risk prediction of severe degenerative mitral regurgitation patients undergoing mitral valve surgery’, by S. Kwak et al., https://doi.org/10.1093/ehjci/jead077. Mitral regurgitation (MR) is the most prevalent valve disease.1 Two distinct entities of MR, which differ in their aetiology, consequences, and prognosis, have been defined. Secondary MR develops in patients with left ventricular (LV) or left atrial (LA) dysfunction.2 Its prevalence is underestimated as in secondary MR; the intensity of the murmur does not correlate with the severity of MR.3 Its management remains a conundrum. The present study focused on primary MR implies valvular lesions and are usually degenerative. The most frequent lesions are present in the leaflets and the chordae, inducing prolapse or flail mitral valve. The indications of intervention apply to patients with severe MR [effective regurgitant orifice area ≥0.4 cm²; regurgitant volume ≥ 60 mL, and a regurgitant fraction (RF) ≥ 50%]. An intervention is indicated if the patient is symptomatic and when the symptoms are related to the valve disease. In asymptomatic patients, surgery should be considered when volume overload and/or dysfunction are present. The cut-off values are LV end-systolic dimension ≥40 mm, LV ejection fraction ≤ 60%, or LA volume ≥60 mL/m².4 The Heart Team is essential for appropriate decisions. When surgery is indicated, mitral repair is far more preferable than valve replacement.5 The percentage of repair depends on the aetiology of MR, the mechanism of dysfunction, the expertise of the surgeon, and the complexity of valvular lesions. The short and long-term prognosis of the patients do not only relate to the efficacy of the repair but also to the age and co-morbidities of the patients. Combined surgery or absence of treatment of tricuspid regurgitation may have a role on prognosis. In high-risk patients, transcatheter edge-to-edge repair may be considered.6 Therefore, risk prediction models for time-to-event outcomes have an important role for clinical decision making. Different methods are available. Frequently, the Cox landmarking method is used, which relies on proportional hazards model. Another approach consists in random survival forests (RSF), which is a machine learning algorithm to predict time-to-event outcome.7 This method can capture complex relationships between the predictors and survival without requiring specification. It has been shown to have higher predictive accuracy than Cox models. However, several limitations of the RSF must also be acknowledged: interpretability, depending on the large number of decision trees; the bias-variance tradeoff towards the training data, which can lead to overfitting; the need of very large sample size; the sensitivity of the model to outliers; and the number of censored observations in the dataset. Not all of these parameters were provided. Ideally, the validation cohort should be external, which was also not the case in the present study. In this issue of the Journal, Kwak et al. used this method to construct a risk model for predicting 3-year all-cause mortality after surgical repair or replacement.8 They included 1521 patients; 70% of the population serve as a training set and the other 30% as a test set.

  • Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

    by Michal Pazdernik, Bernard Iung, Bulent Mutlu, François Alla, Robert Riezebos, William Kong, Maria Carmo Pereira Nunes, Luc Pierard, Ilija Srdanovic, Hirotsugu Yamada, et al.

  • Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

    by Michal Pazdernik, Bernard Iung, Bulent Mutlu, François Alla, Robert Riezebos, William Kong, Maria Carmo Pereira Nunes, Luc Pierard, Ilija Srdanovic, Hirotsugu Yamada, et al.

    Purpose High mortality and a limited performance of valvular surgery are typical features of infective endocarditis (IE) in octogenarians, even though surgical treatment is a major determinant of a successful outcome in IE. Methods Data from the prospective multicentre ESC EORP EURO-ENDO registry were used to assess the prognostic role of valvular surgery depending on age. Results As compared to < 80 yo patients, ≥ 80 yo had lower rates of theoretical indication for valvular surgery (49.1% vs. 60.3%, p < 0.001), of surgery performed (37.0% vs. 75.5%, p < 0.001), and a higher in-hospital (25.9% vs. 15.8%, p < 0.001) and 1-year mortality (41.3% vs. 22.2%, p < 0.001). By multivariable analysis, age per se was not predictive of 1-year mortality, but lack of surgical procedures when indicated was strongly predictive (HR 2.98 [2.43–3.66]). By propensity analysis, 304 ≥ 80 yo were matched to 608 < 80 yo patients. Propensity analysis confirmed the lower rate of indication for valvular surgery (51.3% vs. 57.2%, p = 0.031) and of surgery performed (35.3% vs. 68.4%, p < 0.0001) in ≥ 80 yo. Overall mortality remained higher in ≥ 80 yo (in-hospital: HR 1.50[1.06–2.13], p = 0.0210; 1-yr: HR 1.58[1.21–2.05], p = 0.0006), but was not different from that of < 80 yo among those who had surgery (in-hospital: 19.7% vs. 20.0%, p = 0.4236; 1-year: 27.3% vs. 25.5%, p = 0.7176). Conclusion Although mortality rates are consistently higher in ≥ 80 yo patients than in < 80 yo patients in the general population, mortality of surgery in ≥ 80 yo is similar to < 80 yo after matching patients. These results confirm the importance of a better recognition of surgical indication and of an increased performance of surgery in ≥ 80 yo patients.


  • Age-related characteristics of infective endocarditis: prospective data from the Euro-Endo registry

    by M Pazdernik, C Selton-Suty, P Lancellotti, W.K.F Kong, I Srdanovic, H Yamada, R.K Riezebos, A De Martino, L Pierard, M Nunes, et al.

    Introduction: The profile of infective endocarditis (IE) is continuously evolving over time, and this may probably be partly due to increasing age of the patients. Methods: All data were collected from the EURO-ENDO registry, which is a one-year prospective international multicentre observational survey on patients with definite or possible IE included between 2016 and 2018. Subjects were stratified into 3 groups according to their age at index hospitalization. Results: Among the 3113 patients included, 1670 patients (54%, Young group) were <65, 1068 (34%, Medium group) between 65 and 80 and 375 (12%, Old group) ≥80 years old. The most striking age-related differences were (old group vs others) (table 1) 1) the higher comorbidity burden and Charlson index; 2) the lower rate of embolic events on admission and under therapy; 3) the higher rate of Enterocci and digestive streptococci; 4) the lower rate of surgery during acute IE despite a theoretical indication; 5) the higher in-hospital and 1-year mortality. With regards to surgery, young and medium age were predictive of more frequent performance of surgery as compared to old age (Young: OR 4.33, 95% CI [3.09–6.06], Medium: 3.62, [2.57–5.10], p<0.001). In multivariable analysis, age per se was not predictive of in-hospital and 1yr FU mortality, but lack of surgical procedures when indicated (27% of the old group), was strongly predictive. Conclusion: This is the largest contemporary registry showing the strong influence of age on the demographic, clinical, therapeutic, and prognostic profile of IE. Non-performance of surgical procedures when indicated is frequent in old patients and is a strong predictor of mortality while age per se is not. Endocarditis Teams should take these results into account when considering surgery in elderly patients. Funding Acknowledgement: Type of funding source: Other. Main funding source(s): EORP grant


  • Mitral Stenosis

    by Luc Pierard